Cary Street Partners Investment Advisory LLC Novartis Ag Transaction History

Cary Street Partners Investment Advisory LLC

  • $207 Billion
  • Q2 2025

A detailed history of Cary Street Partners Investment Advisory LLC transactions in Novartis Ag stock. As of the latest transaction made, Cary Street Partners Investment Advisory LLC holds 1,436 shares of NVS stock, worth $171,329. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,436
Previous 1,155 24.33%
Holding current value
$171,329
Previous $129 Million 34.96%
% of portfolio
0.08%
Previous 0.07%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
BUY
$101.96 - $121.01 $28,650 - $34,003
281 Added 24.33%
1,436 $174 Million
Q1 2025

May 09, 2025
BUY
$97.14 - $115.57 $82,763 - $98,465
852 Added 281.19%
1,155 $129 Million
Q4 2024

Feb 14, 2025
SELL
$96.78 - $117.18 $834,243 - $1.01 Million
-8,620 Reduced 96.6%
303 $29.5 Million
Q3 2024

Oct 30, 2024
SELL
$106.13 - $120.89 $132,344 - $150,749
-1,247 Reduced 12.26%
8,923 $1.03 Million
Q2 2024

Jul 22, 2024
SELL
$92.57 - $107.37 $25,734 - $29,848
-278 Reduced 2.66%
10,170 $1.08 Million
Q1 2024

Apr 30, 2024
BUY
$95.27 - $108.47 $38,298 - $43,604
402 Added 4.0%
10,448 $1.01 Million
Q4 2023

Feb 07, 2024
BUY
$92.27 - $101.54 $926,944 - $1.02 Million
10,046 New
10,046 $1.01 Million
Q3 2023

Nov 13, 2023
BUY
$94.73 - $105.13 $474,597 - $526,701
5,010 Added 92.32%
10,437 $1.06 Million
Q2 2023

Aug 10, 2023
SELL
$92.52 - $104.91 $149,882 - $169,954
-1,620 Reduced 22.99%
5,427 $547,000
Q1 2023

May 12, 2023
BUY
$80.03 - $92.81 $1,920 - $2,227
24 Added 0.34%
7,047 $648,000
Q4 2022

Feb 14, 2023
SELL
$75.55 - $92.52 $20,625 - $25,257
-273 Reduced 3.74%
7,023 $637,000
Q3 2022

Nov 14, 2022
BUY
$74.61 - $87.26 $56,181 - $65,706
753 Added 11.51%
7,296 $555,000
Q2 2022

Aug 15, 2022
BUY
$80.52 - $93.75 $526,842 - $613,406
6,543 New
6,543 $553,000
Q3 2021

Nov 15, 2021
SELL
$81.78 - $95.14 $153,501 - $178,577
-1,877 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$85.24 - $94.15 $65,634 - $72,495
770 Added 69.56%
1,877 $171,000
Q1 2021

May 17, 2021
SELL
$83.5 - $98.47 $172,845 - $203,832
-2,070 Reduced 65.16%
1,107 $95,000
Q4 2020

Feb 12, 2021
SELL
$78.07 - $94.43 $4.55 Million - $5.5 Million
-58,259 Reduced 94.83%
3,177 $300,000
Q3 2020

Nov 12, 2020
BUY
$82.14 - $91.0 $5.05 Million - $5.59 Million
61,436 New
61,436 $5.34 Million

Others Institutions Holding NVS

# of Institutions
1,550
Shares Held
140M
Call Options Held
1.69M
Put Options Held
1.87M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $257B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Cary Street Partners Investment Advisory LLC Portfolio

Follow Cary Street Partners Investment Advisory LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cary Street Partners Investment Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cary Street Partners Investment Advisory LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email